<DOC>
	<DOCNO>NCT02583776</DOCNO>
	<brief_summary>Neonatal hypoglycemia associate brain injury impair neurodevelopment outcomes low birth weight infant ( VLBWI ) . Glycemic monitoring usually perform capillary central line sample identify 81 % hypoglycemic episode preterm newborn . The investigator aim assess continuous glucose monitor ( CGM ) use maintain euglycemia ( define target value 72-144mg/dl ) VLBWI . It enrol newborns ≤32 week gestational age and/or birthweight ≤1500 g , within 48 hour life , randomize two study arm , wear Dexcom G4 Platinum CGM : 1 ) Unblinded group ( UB ) : glucose daily intake modulate accord CGM ( Dexcom G4 Platinum ) first 7 day life , alarm hypos/hyper active ; 2 ) Blinded group ( B ) , glucose infusion rate modify accord 2-3 daily capillary glucose test , alarm hypos switch . Pain insertion evaluate validated Premature Infant Pain Profile ( PIPP ) scale . The estimated numerosity 50 patient ( 25 arm ) .</brief_summary>
	<brief_title>Continuous Glucose Monitoring Preterm Infants</brief_title>
	<detailed_description>Background - Neonatal hypoglycemia common event first week life associate brain injury poor neurodevelopment . Unfortunately may unrecognized several hour occurrence , since asymptomatic/poor symptomatic newborn ( Hay WW , 2009 ; Cornblath , 2000 ; Adamkin DH , 2011 ; Burns et al , 2008 ; Wong , 2013 ; Duvanel et al , 1999 ) Despite dramatic consequence prolong hypoglycemia neonatal brain well know , tool recognize represent capillary glycemic test perform accord risk-based protocol Neonatal Intensive Care Units ( NICUs ) : consider limit window intervention base 2-3 glycemic test day ( Thomas F et al , J. Diab Science Technol . 2014 ) . Continuous glucose monitor system offer , last decade , new powerful tool recognize hypoglycemic event neonates traditional monitoring . All work develop neonate , date , aim evaluate performance CGM device use record effect medical `` intervention '' correction hypo hyperglycemia ( Neonatal Insulin Replacement Therapy Europe ( NIRTURE , Beardsall et al , NEJM 2008 ; McKinlay et al , NEJM 2015 ) ( Harris et al J Pediatrics , 2010 ; Beardsall et al , Arch Dis Child Fetal Neonatal 2013 ) . The CGM never use drive medical inteventions newborn evaluate independent tool improve time-in-target glycemia . Previous study demonstrate 81 % hypoglycemic episode detect blood glucose measurement ( Harris et al , J Pediatrics 2010 ) . All publish study neonate , date , use Medtronic CGM system ( Medtronic , USA ) . No adverse effect , associate implant CGM , report neither late-preterm neither preterm newborns . Glycemic control term , moreover , preterm newborn still represent challenge physician wide fluctuation ( hyperglycemia hypoglycemia ) commonly observe population still remain difficult manage traditional blood glucose monitoring ( data/day , delay therapeutic intervention ) . Aim - The study Investigators go conduct aim evaluate CGM , driver therapeutic decision preterm newborn ( birthweight ≤1500g , gestational age ≤32 week ) first week life , may able maintain `` euglycemia '' . Euglycemia define value within range 72-144mg/dl ( 4-8mmol/L ) ( Harris et al J Pediatrics , 2010 ; Beardsall et al , Arch Dis Child Fetal Neonatal Ed 2013 ) Study design - Randomized Controlled Trial - Patients : newborn GA ≤32weeks and/or BW≤ 1500 g. They enrol within first 48 hour life - Intevention group : Unblinded CGM ( DexcomG4Platinum ) data adequate daily glucose intake - Control group : Blinded CGM daily glucose intake adequated accord SMBG ( =2 blood glucose/day ) - Primary Outcome : evaluate Unblinded CGM increase time within `` euglycemic '' range ( 72-144mg/dl ) Materials Methods - Dexcom G4 Platinum ( Dexcom Inc , CA - USA ) sensor apply within 48 hour birth study population lateral side thigh , parent ' consent collection . All patient randomize blind unblinded group application CGM . Randomization perform use randomization list electronically generate . Unblinded group ( intervention/open CGM group ) : wear CGM 7 day , alarm CGM switch daily intake carbohydrate adapt accord CGM data . The study staff record data every three hour absence hypo alarm ( see carbs adjustment procedure ) . Blinded group : wear CGM 7 day , alarm CGM monitor blind . At least two calibration day , accord manufacturer instruction , insert . The daily amount carbohydrate decide accord blood glucose test ( least 2/day ) recommendation American Academy Pediatrics ( see ) . Numerosity : estimate numerosity 50 patient accord primary outcome . Unfortunately data available population ; 10 extra patient recruit case premature interruption recording ( due sensor detachment , malfunction , loss patient interruption monitoring due local/systemic complication ) order ensure total amount 250 day monitoring ( 50 % UB-CGM group 50 % B-CGM group ) maximum amount 350 day monitoring . So estimated time monitoring expect min 250 , max 350 day , divide two group . Reasons study interruption : local and/or systemic complication due application device , transfer patient another center care , withdrawal consent , death , malfunction device . Reasons interruption monitoring specify final report . Carbohydrates adjustment procedure : procedure carbohydrates adjustment us worksheet described Agus MSD , Steil G et al NEJM 2012 adapt NICU standard nutrition suggest American Academy Pediatrics . The worksheet set accord NICU protocols agreement recommendation American Academy Pediatrics , Committee Nutrition . The 1st day intake set 6-8gr/kg carbohydrate ; default daily increase 1gr/kg/day case euglycemia apply ; increase may variate accord CGM data unblinded group 2 glycemic test perform blind group order achieve target following : i. average &gt; = 180 mg/dL decrease calculate GIR 1 g/kg/d ii . If average 144 179 mg/dL make adjustment iii . If average 72 143 mg/dL check minimum GIR reach increase value minimum GIR day iv . If average low 72 mg/dL increase rate either minimum rate + 2 calculated rate plus 2 , whichever big ; v. glycemia &lt; 41mg/gl : increase 2.8g/kg/die GIR perform bolus 2ml/kg/d G10 % . Details worksheet describe Agus et al ( NEJM2012 ) . Worksheet design consider follow : Target 108,00 Low limit 72,00 High limit 144,00 Hyper Theshold 180,00 Hypo Threshold 40,00 A decrease consider hyper threshold 1g/kg/d minimum GIR 4.5g/k/d . No increase perform 144 180mg/dl . Data analysis perform intention treat ( ITT ) . Discussion : perspective limit - Euglycemia definition remain controversial neonatology . Even though , study , decide adopt NIRTURE target ( Beardsall et al , 2010 ) consider optimal range 72 mg/dl ( 4 mmol/L ) 144mg/dl ( 8 mmol/L ) . Values 40mg/dl require G10 % bolus ( 2ml/kg ) increase 2.8gr/kg intake carbs ; value 40 77mg/dl require increase carbs adapt reach middle point expect target . Similarly value upper limit consider decrease carbs intake ( minimum 4.5gr/kg/day ) . The main difference two study group represent number information available physician , consequently , number change glucose intake . The use worksheet allow investigator avoid inter-individuals variability make infusion change standardize intervention two group . Actually traditional system monitor glycemia demonstrate unable detect significant number glycemic variation daytime . Increasing number blood glycemic test ( heel prick ) would mean increase number painful procedure newborn uncertain benefit workload staff . Disclosures : Dexcom Inc , USA provide material study donation Neonatal Intensive Care Unit University Hospital Padua , Italy . The study design no-profit research project Principal Investigators Collaborators Neonatal Intensive Care Unit University Padua , Department Bioengineering ( University Padua ) Boston Children 's Hospital . Dexcom Inc involve study design involve result evaluation .</detailed_description>
	<mesh_term>Hypoglycemia</mesh_term>
	<mesh_term>Birth Weight</mesh_term>
	<criteria>Inclusion Criteria ( and/or ) : &lt; = 32 week gestation birthweight &lt; 1500 g birthweight &lt; 500g malformative syndrome lack parental consent chromosomal abnormality</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>2 Days</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>continuous glucose monitoring ( cgm )</keyword>
	<keyword>neonatal hypoglycemia</keyword>
	<keyword>low birth weight infant ( VLBWI )</keyword>
	<keyword>preterm infant</keyword>
</DOC>